Transfusion Technologies

What Transfusion Technologies does

Transfusion Technologies has no verifiable operating presence in the available source data. The aggregated input contains no information about an active company by this name: no corporate registration data, no leadership team, no employees, no products or services, no revenue, no funding history, no customers, no partnerships, no office locations, and no technology stack. Every structural field in the input — founded year, company type, domicile, parent company, subsidiaries, API/SDK, integrations, AI modalities, certifications, awards, patents, and social media — is empty or marked undeterminable. Operating status is recorded as unable to be determined from the source material.

The only sourced factual artifact associated with the name is the registration status of the internet domain TransfusionTech.com. This domain is being offered for resale on HugeDomains.com, a domain marketplace that has operated since 2005, at a one-time price of $4,595 with an alternative payment plan of $191.46 per month for 24 months at 0% interest. The listing includes a standard 30-day money-back guarantee and SSL-secured checkout via PayPal or Escrow.com, but contains no business description, product offering, team information, or company background. The source data explicitly states that the page does not reference any actual company operations, ownership structure, or business activities associated with Transfusion Technologies, and that the entity's operating status cannot be determined.

No proprietary technology, products, partnerships, awards, certifications, patents, AI modalities, or integration surface is documented. The available evidence does not support any conclusion that a functioning commercial entity currently operates under the Transfusion Technologies name, nor that any such entity has previously existed at scale.

Name

Transfusion Technologies

Website

http://transfusiontech.com

Company type

Private

Founded year

1993

Headcount range

11–50 employees

Short description

Transfusion Technologies has no verifiable operating information in available sources. The only trace is the domain TransfusionTech.com listed for resale on HugeDomains.com at $4,595; no products, customers, technology, leadership, or revenue data could be identified.

Ownership category

akta.pro rank

Product category

Medical Devices / Transfusion Technology (per company name; unverified)

NAICS

Blood and Organ Banks (621991)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Blood Bank, Transfusion Medicine & Immunohematology (HLAHAAAH)

akta.pro secondary industry

Transfusion Medicine & Immunohematology (Blood Bank) (HLAFAMAG)

Keywords

• Medical device technology
• Blood transfusion equipment
• Transfusion medical systems
• Healthcare technology products
• Clinical transfusion solutions

Headquarters

HQ city

Natick

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Others

Core offering

No information is available regarding an actual operating business called Transfusion Technologies. The source material only references the domain name TransfusionTech.com, which is listed for sale on the HugeDomains marketplace at $4,595 (or $191.46 per month for 24 months). There is no evidence of products, services, or commercial activity associated with the company.

Differentiator

Problem solved

Functional benefit

Products and services

• TransfusionTech.com (domain name) The domain name TransfusionTech.com is listed for sale on the HugeDomains marketplace at a price of $4,595 (one-time) or $191.46/month for 24 months. No actual company product or service information is available from this source.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Direct peers

• Terumo BCT: Terumo BCT is the global leader in blood component collection, therapeutic apheresis, and cell-therapy technologies — directly comparable to a 'Transfusion Technologies' company based on the implied category. They manufacture equipment, software, and disposables used in blood collection, processing, and transfusion workflows worldwide.
• Haemonetics: Haemonetics provides blood and plasma component management solutions, including devices and consumables for blood collection, processing, and transfusion medicine. Their product portfolio (e.g., TEG, Cell Salvage, plasma collection) sits squarely in the transfusion-technology category implied by the subject's name.
• Fresenius Kabi: Fresenius Kabi operates a Transfusion Medicine and Cell Therapies business unit focused on blood collection bags, transfusion sets, and plasma products. They are a direct category competitor to anything positioned as 'Transfusion Technologies.'
• Immucor (Werfen): Immucor, now part of Werfen, specializes in transfusion and transplantation diagnostics, particularly immunohematology reagents and instruments used in blood banks. Their Echo and NEO instruments are deployed in transfusion medicine labs worldwide.
• Ortho Clinical Diagnostics: Ortho Clinical Diagnostics develops immunohematology and blood-banking testing solutions (e.g., the ORTHO VISION platform) used in pre-transfusion compatibility testing workflows. They are a direct category peer in transfusion diagnostics.
• Quotient: Quotient is a transfusion diagnostics company focused on pre-transfusion blood group serology testing (MosaiQ platform). They are a focused transfusion-medicine player and direct category peer.

Broad incumbents

• Bio-Rad Laboratories: Bio-Rad operates a Clinical Diagnostics division that includes blood-typing reagents and immunohematology products (e.g., IH-Reader, IH-Com). As a broader life-science incumbent, they overlap with the subject's implied transfusion-medicine category but across a much wider portfolio.
• Grifols: Grifols is a global plasma-derived-medicines and transfusion-medicine company with diagnostic solutions for blood banks (e.g., Procleix, DG Gel). They are a broad incumbent with significant overlap in the transfusion category.

Emerging players

• Macopharma: Macopharma is a mid-sized player specializing in blood-collection systems, transfusion sets, and plasma products. They are a focused, regional (European-headquartered) transfusion-medicine peer with comparable category offerings.
• Verax Biomedical: Verax Biomedical develops platelet-safety and bacterial-detection products (PGDpr) used in the blood-transfusion supply chain. They are a niche emerging player with focused overlap in transfusion safety technology.

Market position

Strengths1 record

Weaknesses3 records

Key risks5 records

Key highlights1 record

Customer concentration

• Xx.com/transfusiontech

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Transfusion Technologies